Janssen Claps Back At Challenge To Stelara Patent
By Alex Baldwin ( September 15, 2023, 7:18 PM BST) -- Janssen Biotech Inc. has pushed back on claims from a subsidiary of Indian pharma giant Intas Pharmaceutical Ltd. that a patent for its blockbuster immunosuppressant Stelara should be revoked as intellectual property protections for the drug wind down....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.